Section : Acné

Acné – 2005

An evaluation of the efficacy and safety of tazarotene (0.1%) cream in acne vulgaris.
Nigam PK, Anant S.
Indian J Dermatol Venereol Leprol. 2005 Sep-Oct;71(5):360-1.

Tolerance and safety of superficial chemical peeling with salicylic acid in various facial dermatoses.
Bari AU, Iqbal Z, Rahman SB.
Indian J Dermatol Venereol Leprol. 2005 Mar-Apr;71(2):87-90.

Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands.
Alestas T, Ganceviciene R, Fimmel S, Müller-Decker K, Zouboulis CC.
J Mol Med. 2006 Jan;84(1):75-87.

The importance of screening for laser-assisted in situ keratomileusis operation (LASIK) before prescribing isotretinoin.
Miles S, McGlathery W, Abernathie B.
J Am Acad Dermatol. 2006 Jan;54(1):180-1.

Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris.
Leyden JJ, Krochmal L, Yaroshinsky A.
J Am Acad Dermatol. 2006 Jan;54(1):73-81.

Hirsutism and the variable response of the pilosebaceous unit to androgen.
Rosenfield RL.
J Investig Dermatol Symp Proc. 2005 Dec;10(3):205-8. Review.

Paradoxical rise in serum adiponectin concentration in the face of acid-induced insulin resistance 13-cis-retinoic.
Koistinen HA, Remitz A, Koivisto VA, Ebeling P.
Diabetologia. 2006 Feb;49(2):383-6.

Prevalence, knowledge, beliefs and psychosocial impact of acne in University students in Central Saudi Arabia.
Al Robaee AA.
Saudi Med J. 2005 Dec;26(12):1958-61.

Investigation of degradation products in a topical gel containing erythromycin and benzoyl peroxide by liquid chromatography-mass spectrometry.
Haghedooren E, Raju V S KK, Dehouck P, Govaerts C, Schepdael AV, Hoogmartens J, Adams E.
J Pharm Biomed Anal. 2006 Apr 11;41(1):165-75.

[Systemic acne therapy].
Thielitz A, Gollnick H.
J Dtsch Dermatol Ges. 2005 May;3(5):366-78; quiz 379-80, 382. Review. German.

Treating acne with oral contraceptives: use of lower doses.
Huber J, Walch K.
Contraception. 2006 Jan;73(1):23-9. Review.

Use of lasers and light-based therapies for treatment of acne vulgaris.
Mariwalla K, Rohrer TE.
Lasers Surg Med. 2005 Dec;37(5):333-42. Review.

There is no correlation between acne severity and AQOLS/DLQI scores.
Ilgen E, Derya A.
J Dermatol. 2005 Sep;32(9):705-10.

Belara–a reliable oral contraceptive with additional benefits for health and efficacy in dysmenorrhoea.
Zahradnik HP.
Eur J Contracept Reprod Health Care. 2005;10 Suppl 1:12-8.

Successful acne management in Apert syndrome twins.
Benjamin LT, Trowers AB, Schachner LA.
Pediatr Dermatol. 2005 Nov-Dec;22(6):561-5.

[The menstrual cycle and the skin].
Grabmeier B, Landthaler M, Hohenleutner S.
J Dtsch Dermatol Ges. 2005 Jan;3(1):52-63; quiz 64-5. Review. German.

[Adjunctive treatments for acne therapy].
Degitz K, Plewig G.
J Dtsch Dermatol Ges. 2005 Feb;3(2):92-6. Review. German.

Acne, lasers, and light.
Ross EV.
Adv Dermatol. 2005;21:1-32. Review.

Acne guideline 2005 update.
Sinclair W, Jordaan HF; Global Alliance to Improve Outcomes in Acne.
S Afr Med J. 2005 Nov;95(11 Pt 2):881-92. Review.

Prevalence of skin diseases among male adolescent and post-adolescent boarding school students in Turkey.
Tuncel AA, Erbagci Z.
J Dermatol. 2005 Jul;32(7):557-64.

Epidermolytic hyperkeratosis as an incidental finding in drug-induced acne.
Lee SJ, Jang Y, Kim D, Na G, Lee W.
J Dermatol. 2005 Aug;32(8):686-7.

Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome.
Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M, Kimmig R, Benson S, Balamitsa E, Elsenbruch S.
Eur J Endocrinol. 2005 Dec;153(6):853-60.

Enhancing the care and treatment of skin of color, part 1: The broad scope of pigmentary disorders.
Taylor SC.
Cutis. 2005 Oct;76(4):249-55. Review.

Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris.
Hong SB, Lee MH.
Photodermatol Photoimmunol Photomed. 2005 Dec;21(6):322-5.

Dairy and acne–the iodine connection.
Arbesman H.
J Am Acad Dermatol. 2005 Dec;53(6):1102.

Diet and acne–slim evidence, again.
Bershad SV.
J Am Acad Dermatol. 2005 Dec;53(6):1102; author reply 1103.

Elevated 17-hydroxyprogesterone serum values in male patients with acne.
Placzek M, Arnold B, Schmidt H, Gaube S, Keller E, Plewig G, Degitz K.
J Am Acad Dermatol. 2005 Dec;53(6):955-8.

Isotretinoin-related optic disc swelling.
Wenham CJ, Clarke I, Shun Shin GA.
Br J Hosp Med (Lond). 2005 Nov;66(11):644-5.

Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne.
Coates P, Vyakrnam S, Ravenscroft JC, Stables GI, Cunliffe WJ, Leyden JJ, Johnson J, Eady EA, Cove JH.
Br J Dermatol. 2005 Dec;153(6):1126-36. Erratum in: Br J Dermatol. 2006 Apr;154(4):807.

Induction of toll-like receptors by Propionibacterium acnes.
Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, Khammari A, Dreno B.
Br J Dermatol. 2005 Dec;153(6):1105-13.

Cystic acne improved by photodynamic therapy with short-contact 5-aminolevulinic acid and sequential combination of intense pulsed light and blue light activation.
Melnick S.
J Drugs Dermatol. 2005 Nov-Dec;4(6):742-5.

An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne.
Cunliffe WJ, Fernandez C, Bojar R, Kanis R, West F; Zindaclin Clinical Study Group.
J Dermatolog Treat. 2005;16(4):213-8.

Medicine by media: did a critical television documentary affect the prescribing of cyproterone–estradiol (Diane-35)?
Mintzes B, Morgan S, Bassett KL.
CMAJ. 2005 Nov 22;173(11):1313-5.

Oh, no! Not at my age!
Querna B.
US News World Rep. 2005 Nov 14;139(18):78.

[Treatment of acne].
Fyrand O.
Tidsskr Nor Laegeforen. 2005 Nov 17;125(22):3108-9. Norwegian.

Safety of doxycycline and minocycline: a systematic review.
Smith K, Leyden JJ.
Clin Ther. 2005 Sep;27(9):1329-42. Review.

Nonpsychiatric medical treatment of body dysmorphic disorder.
Crerand CE, Phillips KA, Menard W, Fay C.
Psychosomatics. 2005 Nov-Dec;46(6):549-55.

Cetuximab-induced acne.
Molinari E, De Quatrebarbes J, André T, Aractingi S.
Dermatology. 2005;211(4):330-3.

Low dose isotretinoin combined with tretinoin is effective to correct abnormalities of acne.
Plewig G, Dressel H, Pfleger M, Michelsen S, Kligman AM.
J Dtsch Dermatol Ges. 2004 Jan;2(1):31-45.

[Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies].
Gollnick HP, Graupe K, Zaumseil RP.
J Dtsch Dermatol Ges. 2004 Oct;2(10):841-7. German.

A prospective study of the responsiveness of depression and suicidal ideation in acne patients to different phases of isotretinoin therapy.
Kellett SC, Gawkrodger DJ.
Eur J Dermatol. 2005 Nov-Dec;15(6):484-8.

Comedolytic effect of a novel RARgamma-specific retinoid, ER36009: comparison with retinoic acid in the rhino mouse model.
Sakuta T, Kanayama T.
Eur J Dermatol. 2005 Nov-Dec;15(6):459-64.

Benzoyl peroxide skin washes: basis, logic, effectiveness, and tolerance.
Burkhart CG, Scheinfeld NS.
Skinmed. 2005 Nov-Dec;4(6):370.

Glutathione peroxidase (GSH-Px) enzyme levels of patients with acne vulgaris.
Aybey B, Ergenekon G, Hekim N, Yarat A, Kurai Y, Onsun N.
J Eur Acad Dermatol Venereol. 2005 Nov;19(6):766-7.

[How I prevent … minor acne].
Piérard GE, Piérard-Franchimont C.
Rev Med Liege. 2005 Sep;60(9):741-3. Review. French.

Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.
Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA.
J Clin Endocrinol Metab. 2006 Jan;91(1):2-6.

Antihistamines may be used as an « adjuvant » in treatment of all kinds of acne.
Yavari V.
Med Hypotheses. 2006;66(2):447-8.

Treatment of acne could lead to the better control of cellular autoimmune disorders.
Namazi MR.
Med Hypotheses. 2006;66(2):446-7.

Trends in prescription of acne medication in the US: shift from antibiotic to non-antibiotic treatment.
Thevarajah S, Balkrishnan R, Camacho FT, Feldman SR, Fleischer AB Jr.
J Dermatolog Treat. 2005;16(4):224-8.

An open study to determine the efficacy of blue light in the treatment of mild to moderate acne.
Morton CA, Scholefield RD, Whitehurst C, Birch J.
J Dermatolog Treat. 2005;16(4):219-23.

Does the teratogenicity of isotretinoin outweigh its benefits?
Jordan AY, Parks L, Chen SC, Higgins K, Fleischer AB, Feldman SR.
J Dermatolog Treat. 2005;16(4):190-2.

Novel drug delivery systems: potential in improving topical delivery of antiacne agents.
Date AA, Naik B, Nagarsenker MS.
Skin Pharmacol Physiol. 2006;19(1):2-16. Review.

Our approach to pediatric dermatologic laser surgery.
Chapas AM, Geronemus RG.
Lasers Surg Med. 2005 Oct;37(4):255-63.

[Minocycline-induced lupus-like disease].
Leydet H, Armingeat T, Pham T, Lafforgue P.
Rev Med Interne. 2006 Jan;27(1):72-5. French.

[Clinical variants of acne].
Jansen T, Grabbe S, Plewig G.
Hautarzt. 2005 Nov;56(11):1018-26. Review. German.

[Acne, dermatologists, cosmetics and the PP (publicity product)].
Poli F.
Ann Dermatol Venereol. 2005 Aug-Sep;132(8-9 Pt 1):629-31. French.

Optical treatments for acne.
Ross EV.
Dermatol Ther. 2005 May-Jun;18(3):253-66. Review.

Photodynamic therapy for cosmetic applications.
Uebelhoer NS, Dover JS.
Dermatol Ther. 2005 May-Jun;18(3):242-52. Review.

Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.
Oh S, Kim SH, Ko Y, Sim JH, Kim KS, Lee SH, Park S, Kim YJ.
Food Chem Toxicol. 2006 Apr;44(4):552-9.

Does facial sebum excretion really affect the development of acne?
Youn SW, Park ES, Lee DH, Huh CH, Park KC.
Br J Dermatol. 2005 Nov;153(5):919-24.

[Propionibacterium acnes adenitis].
Chanet V, Romaszko JP, Rolain JM, Beytout J.
Presse Med. 2005 Aug 27;34(14):1005-6. French.

[Pathophysiology of acne].
Borelli C, Plewig G, Degitz K.
Hautarzt. 2005 Nov;56(11):1013-7. Review. German.

[Dairy products and acne].
Kulkas L.
Duodecim. 2005;121(15):1659; author reply 1659. Finnish.

The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle.
Pariser DM, Thiboutot DM, Clark SD, Jones TM, Liu Y, Graeber M; Adapalene Study Group.
Cutis. 2005 Aug;76(2):145-51.

A qualitative and quantitative assessment of the application and use of topical acne medication by patients.
Del Rosso JQ.
Cutis. 2005 Aug;76(2):109-13.

Pimple positives.
Weinberg JM.
Cutis. 2005 Aug;76(2):96.

[Systemic acne therapy].
Thielitz A, Gollnick H.
Hautarzt. 2005 Nov;56(11):1040-7. Review. German.

Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses.
Kim J.
Dermatology. 2005;211(3):193-8. Review.

[Light, laser and PDT therapy for acne].
Borelli C, Merk K, Plewig G, Degitz K.
Hautarzt. 2005 Nov;56(11):1027-32. Review. German.

Nonablative phototherapy for acne vulgaris using the KTP 532 nm laser.
Baugh WP, Kucaba WD.
Dermatol Surg. 2005 Oct;31(10):1290-6.

Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin.
Papakonstantinou E, Aletras AJ, Glass E, Tsogas P, Dionyssopoulos A, Adjaye J, Fimmel S, Gouvousis P, Herwig R, Lehrach H, Zouboulis CC, Karakiulakis G.
J Invest Dermatol. 2005 Oct;125(4):673-84.

Patients’ perceptions of isotretinoin, depression and suicide–a qualitative study.
Magin P, Adams J, Heading G, Pond D, Smith W.
Aust Fam Physician. 2005 Sep;34(9):795-7.

Treatment of inflammatory facial acne vulgaris with combination 595-nm pulsed-dye laser with dynamic-cooling-device and 1,450-nm diode laser.
Glaich AS, Friedman PM, Jih MH, Goldberg LH.
Lasers Surg Med. 2006 Mar;38(3):177-80.

Common dermatoses in moderately pigmented skin: uncommon presentations.
Abdel-Naser MB, Verma SB, Abdallah MA.
Clin Dermatol. 2005 Sep-Oct;23(5):446-56. Review.

1,450 nm long-pulsed diode laser for nonablative skin rejuvenation.
Doshi SN, Alster TS.
Dermatol Surg. 2005 Sep;31(9 Pt 2):1223-6; discussion 1226.

Improvement of atrophic acne scars with a 1,320 nm Nd:YAG laser: retrospective study.
Bellew SG, Lee C, Weiss MA, Weiss RA.
Dermatol Surg. 2005 Sep;31(9 Pt 2):1218-21; discussion 1222.

Effective and safe use of lasers, light sources, and radiofrequency devices in the clinical management of Asian patients with selected dermatoses.
Chan HH.
Lasers Surg Med. 2005 Sep;37(3):179-85. Review.

[Surgical management of acne inversa].
Weyandt G.
Hautarzt. 2005 Nov;56(11):1033-9. Review. German.

Acne, antibiotics, and upper respiratory tract infections.
Chan AW, Shaw JC.
Arch Dermatol. 2005 Sep;141(9):1157-8.

Antibiotic treatment of acne may be associated with upper respiratory tract infections.
Margolis DJ, Bowe WP, Hoffstad O, Berlin JA.
Arch Dermatol. 2005 Sep;141(9):1132-6.

Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad.
Maintz L, Betz RC, Allam JP, Wenzel J, Jaksche A, Friedrichs N, Bieber T, Novak N.
Eur J Dermatol. 2005 Sep-Oct;15(5):347-52.

Intense pulsed light-mediated photodynamic therapy.
Alexiades-Armenakas M.
J Drugs Dermatol. 2005 Sep-Oct;4(5):657-8.

Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
Bowman S, Gold M, Nasir A, Vamvakias G.
J Drugs Dermatol. 2005 Sep-Oct;4(5):611-8.

Considerations for treating acne in ethnic skin.
Callender VD.
Cutis. 2005 Aug;76(2 Suppl):19-23. Review.

The role of the vehicle in combination acne therapy.
Del Rosso JQ.
Cutis. 2005 Aug;76(2 Suppl):15-8. Review.

Combination therapy is the standard of care.
Tanghetti EA.
Cutis. 2005 Aug;76(2 Suppl):8-14. Review.

The pathophysiology of acne.
Webster GF.
Cutis. 2005 Aug;76(2 Suppl):4-7.

The treatment of acne vulgaris with low dosage doxycycline.
Parish LC, Parish JL, Routh HB, Witkowski JA.
Acta Dermatovenerol Croat. 2005;13(3):156-9.

[Lupus miliaris disseminatus faciei: 6 cases].
Borhan R, Vignon-Pennamen MD, Morel P.
Ann Dermatol Venereol. 2005 Jun-Jul;132(6-7 Pt 1):526-30. French.

Acne vulgaris.
Purdy S.
Clin Evid. 2005 Jun;(13):2038-59. Review.

Isotretinoin prescribing: finding a balance between benefit and risk.
Stern RS.
Pharmacoepidemiol Drug Saf. 2005 Sep;14(9):611-3.

[Benzoyl peroxide action and cost effectiveness].
Kreutzkamp B.
Med Monatsschr Pharm. 2005 Aug;28(8):295. German.

[Full face dermabrasion for acne scars].
Cai GB, Li HD, Zhang Y, Liu L, Chen GY, Li TY, Wang LZ, Tian YJ, Li BB, Gong GH.
Zhonghua Zheng Xing Wai Ke Za Zhi. 2005 May;21(3):192-3. Chinese.

Acne and active patients: improving more than superficial appearances.
Pleacher MD, Dexter WW.
Phys Sportsmed. 2005 Sep;33(9):14-26.

[Side effects of treatment with isotretinoin in patients with acne].
Bergler-Czop B, Brzezinska-Wcislo L.
Pol Merkur Lekarski. 2005 Jun;18(108):680-5. Polish.

Isotretinoin-induced elkonyxis.
Yung A, Johnson P, Goodfield MJ.
Br J Dermatol. 2005 Sep;153(3):671-2.

[Methods for treating various forms of acne in the years 1991-2000, Department of Dermatology, Silesian Medical School].
Bergler-Czop B, Brzezinska-Wcislo L.
Wiad Lek. 2005;58(3-4):156-60. Polish.

Acne, depression, and suicide.
Hull PR, D’Arcy C.
Dermatol Clin. 2005 Oct;23(4):665-74. Review.

Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes.
McInturff JE, Wang SJ, Machleidt T, Lin TR, Oren A, Hertz CJ, Krutzik SR, Hart S, Zeh K, Anderson DH, Gallo RL, Modlin RL, Kim J.
J Invest Dermatol. 2005 Aug;125(2):256-63.

Estrogens and the skin.
Brincat MP, Baron YM, Galea R.
Climacteric. 2005 Jun;8(2):110-23. Review.

Lasers and light therapy for acne vulgaris.
Bhardwaj SS, Rohrer TE, Arndt K.
Semin Cutan Med Surg. 2005 Jun;24(2):107-12. Review.

Hormonal therapy for acne using oral contraceptive pills.
Harper JC.
Semin Cutan Med Surg. 2005 Jun;24(2):103-6. Review.

Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review.
Marqueling AL, Zane LT.
Semin Cutan Med Surg. 2005 Jun;24(2):92-102. Review.

Implications for the role of diet in acne.
Cordain L.
Semin Cutan Med Surg. 2005 Jun;24(2):84-91. Review.

The role of inflammation in the pathogenesis of acne and acne scarring.
Holland DB, Jeremy AH.
Semin Cutan Med Surg. 2005 Jun;24(2):79-83. Review.

The role of toll-like receptors in the pathophysiology of acne.
McInturff JE, Kim J.
Semin Cutan Med Surg. 2005 Jun;24(2):73-8. Review.

Insights in the pathogenic potential of Propionibacterium acnes from its complete genome.
Brüggemann H.
Semin Cutan Med Surg. 2005 Jun;24(2):67-72. Review.

Introduction: welcome to the next generation of acne research.
Zane LT.
Semin Cutan Med Surg. 2005 Jun;24(2):65-6.

Acne is not a stigma of HIV infection: a review of 36 patients.
Almagro M, Del Pozo J, García-Silva J, Pérez-García M, Rodríguez-Lozano J, Pértega S, Fonseca E.
Dermatology. 2005;211(2):114-7.

Treatment of acne with topical antibiotics: lessons from clinical studies.
Simonart T, Dramaix M.
Br J Dermatol. 2005 Aug;153(2):395-403. Review.

Severe acne infantum successfully treated with isotretinoin.
Torrelo A, Pastor MA, Zambrano A.
Pediatr Dermatol. 2005 Jul-Aug;22(4):357-9.

Applications of aminolevulinic Acid-based photodynamic therapy in cosmetic facial plastic practices.
Zakhary K, Ellis DA.
Facial Plast Surg. 2005 May;21(2):110-6. Review.

Make-up improves the quality of life of acne patients without aggravating acne eruptions during treatments.
Hayashi N, Imori M, Yanagisawa M, Seto Y, Nagata O, Kawashima M.
Eur J Dermatol. 2005 Jul-Aug;15(4):284-7.

Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris.
Alirezaï M, Gerlach B, Horvath A, Forsea D, Briantais P, Guyomar M.
Eur J Dermatol. 2005 Jul-Aug;15(4):274-8.

Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone in the treatment of acne vulgaris: comparative study.
Santos MA, Belo VG, Santos G.
Dermatol Surg. 2005 Aug;31(8 Pt 1):910-5.

Comparison of a 1,064 nm laser and a 1,320 nm laser for the nonablative treatment of acne scars.
Yaghmai D, Garden JM, Bakus AD, Massa MC.
Dermatol Surg. 2005 Aug;31(8 Pt 1):903-9.

Cosmetics in the treatment of acne vulgaris.
Toombs EL.
Dermatol Clin. 2005 Jul;23(3):575-81, viii. Review.

Coenraads PJ, Tang NJ.
Contact Dermatitis. 2005 Aug;53(2):123.

Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III.
Schaller M, Loewenstein M, Borelli C, Jacob K, Vogeser M, Burgdorf WH, Plewig G.
Br J Dermatol. 2005 Jul;153(1):66-71.

Evaluation of acne scar treatment with a 1450-nm midinfrared laser and 30% trichloroacetic acid peels.
Carniol PJ, Vynatheya J, Carniol E.
Arch Facial Plast Surg. 2005 Jul-Aug;7(4):251-5.

The new age of acne therapy: light, lasers, and radiofrequency.
Rotunda AM, Bhupathy AR, Rohrer TE.
J Cosmet Laser Ther. 2004 Dec;6(4):191-200. Review.

The development of BRL 7660 as an anti-acne agent.
Bowring N.
Skinmed. 2005 Jul-Aug;4(4):211-3. Review.

Antimicrobial effects of Thai medicinal plants against acne-inducing bacteria.
Chomnawang MT, Surassmo S, Nukoolkarn VS, Gritsanapan W.
J Ethnopharmacol. 2005 Oct 3;101(1-3):330-3.

Minocycline hyperpigmentation isolated to the subcutaneous fat.
Rahman Z, Lazova R, Antaya RJ.
J Cutan Pathol. 2005 Aug;32(7):516-9.

Training room management of medical conditions: sports dermatology.
Cordoro KM, Ganz JE.
Clin Sports Med. 2005 Jul;24(3):565-98, viii-ix. Review.

Case reports: acne fulminans in Marfan syndrome.
Wollina U, Gesina H, Koch A, Köstler E.
J Drugs Dermatol. 2005 Jul-Aug;4(4):501-5.

Superoxide dismutase and myeloperoxidase activities in polymorphonuclear leukocytes in acne vulgaris.
Kurutas EB, Arican O, Sasmaz S.
Acta Dermatovenerol Alp Panonica Adriat. 2005 Jun;14(2):39-42.

[The evaluation of clinical signs and hormonal changes in women who complained of excessive body hair growth].
Kozloviene D, Kazanavicius G, Kruminis V.
Medicina (Kaunas). 2005;41(6):487-95. Lithuanian.

Managing adolescent acne: a guide for pediatricians.
Krowchuk DP.
Pediatr Rev. 2005 Jul;26(7):250-61. Review.

Handling of dioxin measurement data in the presence of non-detectable values: overview of available methods and their application in the Seveso chloracne study.
Baccarelli A, Pfeiffer R, Consonni D, Pesatori AC, Bonzini M, Patterson DG Jr, Bertazzi PA, Landi MT.
Chemosphere. 2005 Aug;60(7):898-906.

Clindamycin/tretinoin: clindamycin phosphate/tretinoin gel.
[No authors listed]
Drugs R D. 2005;6(4):231-4. Review.

[Isotretinoin in danger! So are the dermatologists!].
Beaulieu P, Revuz J.
Ann Dermatol Venereol. 2005 May;132(5):412-3. French.

Childhood granulomatous periorificial dermatitis: lupus miliaris disseminatus faciei in children?
Misago N, Nakafusa J, Narisawa Y.
J Eur Acad Dermatol Venereol. 2005 Jul;19(4):470-3.

[Childhood acne. Clinical expression, etiology, and relationship to juvenile acne].
Jansen T, Grabbe S, Plewig G.
Hautarzt. 2006 Mar;57(3):222, 224-7. German.

« Hidradenitis suppurativa » is acne inversa! An appeal to (finally) abandon a misnomer.
Sellheyer K, Krahl D.
Int J Dermatol. 2005 Jul;44(7):535-40. Review.

Cumulative irritation potential of adapalene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%.
Dosik JS, Homer K, Arsonnaud S.
Cutis. 2005 May;75(5):289-93.

The antimicrobial activities of Psidium guajava and Juglans regia leaf extracts to acne-developing organisms.
Qadan F, Thewaini AJ, Ali DA, Afifi R, Elkhawad A, Matalka KZ.
Am J Chin Med. 2005;33(2):197-204.

‘Nobody likes damaged goods’: the experience of adult visible acne.
Murray CD, Rhodes K.
Br J Health Psychol. 2005 May;10(Pt 2):183-202.

Resolution of acne following therapy with an oral contraceptive in a patient with Apert syndrome.
Hsieh T, Ho N.
J Am Acad Dermatol. 2005 Jul;53(1):173-4.

Body dysmorphic disorder.
Mackley CL.
Dermatol Surg. 2005 May;31(5):553-8. Review.

Drugs for acne, rosacea and psoriasis.
[No authors listed]
Treat Guidel Med Lett. 2005 Jul;3(35):49-56.

Efficacy of issuing guidelines on acne management to general practitioners.
Cusack CM, Buckley CC.
Br J Dermatol. 2005 Jun;152(6):1392-3.

Non-acne dermatologic indications for systemic isotretinoin.
Akyol M, Ozçelik S.
Am J Clin Dermatol. 2005;6(3):175-84. Review.

Invited commentary: Acne in adolescence–protecting the heart but damaging the prostate later in life?
Ford ES, Liu S.
Am J Epidemiol. 2005 Jun 15;161(12):1102-6.

Acne in adolescence and cause-specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort Study.
Galobardes B, Davey Smith G, Jeffreys M, Kinra S, McCarron P.
Am J Epidemiol. 2005 Jun 15;161(12):1094-101.

Case report and review of minocycline-induced cutaneous polyarteritis nodosa.
Culver B, Itkin A, Pischel K.
Arthritis Rheum. 2005 Jun 15;53(3):468-70. Review.

[Assessment of the photosensitization potential of zinc gluconate].
Duteil L, Queille-Roussel C, Ortonne JP.
Ann Dermatol Venereol. 2005 Mar;132(3):219-24. French.

Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome.
Stichweh DS, Punaro M, Pascual V.
Pediatr Dermatol. 2005 May-Jun;22(3):262-5.

Subantimicrobial dose doxycycline: a unique treatment for rosacea.
Berman B, Zell D.
Cutis. 2005 Apr;75(4 Suppl):19-24.

The anti-inflammatory effects of tetracyclines.
Weinberg JM.
Cutis. 2005 Apr;75(4 Suppl):6-11. Review.

Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
Dreno B, Foulc P, Reynaud A, Moyse D, Habert H, Richet H.
Eur J Dermatol. 2005 May-Jun;15(3):152-5.

[The treatment of acne].
Dréno B.
Presse Med. 2005 Apr 9;34(7):540-3. Review. French.

[Pathophysiology of acne].
Dréno B.
Presse Med. 2005 Apr 9;34(7):537-9. Review. French.

Isotretinoin in acne vulgaris: a prospective analysis of 160 cases from Kuwait.
Al-Mutairi N, Manchanda Y, Nour-Eldin O, Sultan A.
J Drugs Dermatol. 2005 May-Jun;4(3):369-73.

Mechanism-based treatment of acne vulgaris: the value of combination therapy.
Webster G.
J Drugs Dermatol. 2005 May-Jun;4(3):281-8. Review.

Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study.
Chia CY, Lane W, Chibnall J, Allen A, Siegfried E.
Arch Dermatol. 2005 May;141(5):557-60.

Adolescents’ experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.
Harel Z, Riggs S, Vaz R, Flanagan P, Dunn K, Harel D.
J Pediatr Adolesc Gynecol. 2005 Apr;18(2):85-90.

Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study.
Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Arsonnaud S, Kang S; Differin Study Group.
Skinmed. 2005 May-Jun;4(3):138-46.

Objective assessment of compliance with treatments in acne.
Zaghloul SS, Cunliffe WJ, Goodfield MJ.
Br J Dermatol. 2005 May;152(5):1015-21.

Photodynamic therapy in dermatology–an update.
Babilas P, Karrer S, Sidoroff A, Landthaler M, Szeimies RM.
Photodermatol Photoimmunol Photomed. 2005 Jun;21(3):142-9. Review.

[Do we have to stop treating acne in summertime?].
Crickx B.
Ann Dermatol Venereol. 2005 Apr;132(4):404-6. French.

Drugs. Adapalene.
[No authors listed]
Nurs Times. 2005 Apr 26-May 2;101(17):33.

Disturbance in the well-being of a patient with acne: suggestions for anticipation and detection.
Möhrenschlager M, Henkel V, Möller HJ, Worret WI, Ring J.
Acta Derm Venereol. 2005;85(2):182-3.

Isotretinoin (Ro-Accutane) teratogenesis. A case report.
Giannoulis CH, Papathanasiou K, Tantanasis TH, Vaitsi V, Tzafettas I.
Clin Exp Obstet Gynecol. 2005;32(1):78.

Ocular surface disorders and tear function changes in nodulo-cystic acne.
Ozdemir M, Ozdemir G, Sasmaz S, Arican O.
J Dermatol. 2005 Mar;32(3):174-8.

Benzoyl peroxide, adapalene, and their combination in the treatment of acne vulgaris.
Korkut C, Piskin S.
J Dermatol. 2005 Mar;32(3):169-73.

Functional brain imaging alterations in acne patients treated with isotretinoin.
Bremner JD, Fani N, Ashraf A, Votaw JR, Brummer ME, Cummins T, Vaccarino V, Goodman MM, Reed L, Siddiq S, Nemeroff CB.
Am J Psychiatry. 2005 May;162(5):983-91. Erratum in: Am J Psychiatry. 2008 Dec;165(12):1614.

Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab.
Iqbal M, Kolodney MS.
J Am Acad Dermatol. 2005 May;52(5 Suppl 1):S118-20.

Acute depression from isotretinoin. Another case.
La Placa M.
J Eur Acad Dermatol Venereol. 2005 May;19(3):387.

Are we starting to induce skin cancer in order to avoid topical steroids?
Niwa Y, Nasr I.
J Eur Acad Dermatol Venereol. 2005 May;19(3):387-9.

Acneiform facial eruptions: a problem for young women.
Cheung MJ, Taher M, Lauzon GJ.
Can Fam Physician. 2005 Apr;51:527-33. Review.

Unsaturated fatty acids induce calcium influx into keratinocytes and cause abnormal differentiation of epidermis.
Katsuta Y, Iida T, Inomata S, Denda M.
J Invest Dermatol. 2005 May;124(5):1008-13.

HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum.
Pérez-Soler R, Delord JP, Halpern A, Kelly K, Krueger J, Sureda BM, von Pawel J, Temel J, Siena S, Soulières D, Saltz L, Leyden J.
Oncologist. 2005 May;10(5):345-56. Review.

[The etiopathogenesis of acne vulgaris–if the diet is an important factor?].
Dziankowska-Bartkowiak B, Dadoush D.
Przegl Lek. 2004;61(12):1448-51. Review. Polish.

Carbopols as factors buffering triethanolamine interacting with artificial skin sebum.
Musial W, Kubis A.
Polim Med. 2004;34(4):17-30. English, Polish.

[Acne vulgaris].
Jessberger B, Worret WI.
Med Monatsschr Pharm. 2005 Apr;28(4):117-22. Review. German.

Body dysmorphic disorder of twins with facial illness after successful isotretinoin therapy.
Erkolahti R, Ilonen T, Eerola M, Saarijärvi S, Majamaa H.
Acta Derm Venereol. 2004;84(6):499-500.

Subcision for acne scarring: technique and outcomes in 40 patients.
Alam M, Omura N, Kaminer MS.
Dermatol Surg. 2005 Mar;31(3):310-7; discussion 317.

Has acne increased? Prevalence of acne history among university students between 1948 and 1968. The Glasgow Alumni Cohort Study.
Galobardes B, Davey Smith G, Jefferys M, McCarron P; Glasgow Alumni Cohort.
Br J Dermatol. 2005 Apr;152(4):824-5.

Congenital oculomotor nerve synkinesis associated with fetal retinoid syndrome.
Morrison DG, Elsas FJ, Descartes M.
J AAPOS. 2005 Apr;9(2):166-8.

Isotretinoin (13-cis-retinoic acid) associated atrial tachycardia.
Hasdemir C, Sagcan A, Sekuri C, Ildizli M, Ulucan C, Ceylan C.
Pacing Clin Electrophysiol. 2005 Apr;28(4):348-9.

The use of topical retinoids for inflammatory acne: a review of the pharmacoeconomic considerations.
Harper J.
Manag Care Interface. 2005 Mar;18(3):51-5. Review.

Clinical practice. Acne.
James WD.
N Engl J Med. 2005 Apr 7;352(14):1463-72. Review.

Cutaneous lasers.
DiBernardo BE, Cacciarelli A.
Clin Plast Surg. 2005 Apr;32(2):141-50.

Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
Leyden JJ, Shalita A, Thiboutot D, Washenik K, Webster G.
Clin Ther. 2005 Feb;27(2):216-24.

Vitamin E does not reduce the side-effects of isotretinoin in the treatment of acne vulgaris.
Kus S, Gün D, Demirçay Z, Sur H.
Int J Dermatol. 2005 Mar;44(3):248-51.

Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris.
Kus S, Yucelten D, Aytug A.
Clin Exp Dermatol. 2005 May;30(3):215-20.

A practical approach for the use of oral isotretinoin for infantile acne.
Barnes CJ, Eichenfield LF, Lee J, Cunningham BB.
Pediatr Dermatol. 2005 Mar-Apr;22(2):166-9.

Formulation and evaluation of an effective pH balanced topical antimicrobial product containing tea tree oil.
Biju SS, Ahuja A, Khar RK, Chaudhry R.
Pharmazie. 2005 Mar;60(3):208-11.

A cross-sectional analysis of quality of life in Japanese acne patients using the Japanese version of Skindex-16.
Hayashi N, Higaki Y, Kawamoto K, Kamo T, Shimizu S, Kawashima M.
J Dermatol. 2004 Dec;31(12):971-6.

Delta-aminolevulinic acid-based photodynamic therapy for acne on the body.
Kimura M, Itoh Y, Tokuoka Y, Kawashima N.
J Dermatol. 2004 Dec;31(12):956-60.

Spencer JM.
Am J Clin Dermatol. 2005;6(2):89-92. Review.

Acne vulgaris: a review of antibiotic therapy.
Tan AW, Tan HH.
Expert Opin Pharmacother. 2005 Mar;6(3):409-18. Review.

Randomized controlled trial of pimecrolimus 1% cream for treatment of facial acne vulgaris.
Tan JK, Morneau K, Fung K.
J Am Acad Dermatol. 2005 Apr;52(4):738-9.

Acne and smoking: is there a relationship?
Firooz A, Sarhangnejad R, Davoudi SM, Nassiri-Kashani M.
BMC Dermatol. 2005 Mar 24;5:2.

Polycystic ovary syndrome.
Ehrmann DA.
N Engl J Med. 2005 Mar 24;352(12):1223-36. Review.

The pathogenesis of acne.
Knor T.
Acta Dermatovenerol Croat. 2005;13(1):44-9.

Teenage acne is influenced by genetic factors.
Evans DM, Kirk KM, Nyholt DR, Novac C, Martin NG.
Br J Dermatol. 2005 Mar;152(3):579-81.

Utility of studying the ocular surface in patients with acne vulgaris treated with oral isotretinoin: a randomized controlled trial.
Aragona P, Cannavò SP, Borgia F, Guarneri F.
Br J Dermatol. 2005 Mar;152(3):576-8.

Reactivation of ophthalmic herpes zoster following pulsed-dye laser treatment for inflammatory acne vulgaris.
Clayton TH, Stables GI.
Br J Dermatol. 2005 Mar;152(3):569-70.

Health status and plasma dioxin levels in chloracne cases 20 years after the Seveso, Italy accident.
Baccarelli A, Pesatori AC, Consonni D, Mocarelli P, Patterson DG Jr, Caporaso NE, Bertazzi PA, Landi MT.
Br J Dermatol. 2005 Mar;152(3):459-65.

Acne vulgaris.
Kerkemeyer K.
Plast Surg Nurs. 2005 Jan-Mar;25(1):31-5. Review.

Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women.
Cappel M, Mauger D, Thiboutot D.
Arch Dermatol. 2005 Mar;141(3):333-8.

Hormonal approach to the treatment of acne a Canadian perspective.
Lynde CW.
J Cutan Med Surg. 2004;8 Suppl 4:1-2.

Psychosocial effects of acne.
Thomas DR.
J Cutan Med Surg. 2004;8 Suppl 4:3-5. Review.

Hormonal therapy of acne.
Haroun M.
J Cutan Med Surg. 2004;8 Suppl 4:6-10. Review.

Hormonal treatment of acne: review of current best evidence.
Tan J.
J Cutan Med Surg. 2004;8 Suppl 4:11-5. Review.

Practical approach to the hormonal treatment of acne.
Poulin Y.
J Cutan Med Surg. 2004;8 Suppl 4:16-21. Review.

Prescribing patterns for topical retinoids within NAMCS data.
Balkrishnan R, Sansbury JC, Shenolikar RA, Fleischer AB Jr, Feldman SR.
J Drugs Dermatol. 2005 Mar-Apr;4(2):172-9.

Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel (Duac) as monotherapy and in combination.
Bikowski JB.
J Drugs Dermatol. 2005 Mar-Apr;4(2):164-71.

Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
Shalita A, Miller B, Menter A, Abramovits W, Loven K, Kakita L.
J Drugs Dermatol. 2005 Mar-Apr;4(2):153-8.

Dioxin toxicity and chloracne in the Ukraine.
Sterling JB, Hanke CW.
J Drugs Dermatol. 2005 Mar-Apr;4(2):148-50.

A review of clinical experience and recommendations for improving patient care.
Weiss J.
Cutis. 2005 Feb;75(2 Suppl):32-8; discussion 39. Review. Erratum in: Cutis. 2005 Apr;75(4):209.

An update on the safety and efficacy of topical retinoids.
Phillips TJ.
Cutis. 2005 Feb;75(2 Suppl):14-22, 24; discussion 22-3. Review.

The mechanism of action of topical retinoids.
Kang S.
Cutis. 2005 Feb;75(2 Suppl):10-3; discussion 13. Review.

Introduction. Contemporary perspectives on topical retinoids.
Leyden JJ.
Cutis. 2005 Feb;75(2 Suppl):4.

A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%.
Zhang JZ, Li LF, Tu YT, Zheng J.
J Dermatolog Treat. 2004 Dec;15(6):372-8.

Depression is not common in isotretinoin-treated acne patients.
Rohrback JM, Fleischer AB Jr, Krowchuk DP, Feldman SR.
J Dermatolog Treat. 2004 Jul;15(4):252.

Topical tretinoin or adapalene in acne vulgaris: an overview.
Jain S.
J Dermatolog Treat. 2004 Jul;15(4):200-7. Review.

The moral of the isotretinoin depression story.
Feldman SR.
J Dermatolog Treat. 2004 Jul;15(4):199.

Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne.
Bialecka A, Mak M, Biedron R, Bobek M, Kasprowicz A, Marcinkiewicz J.
Arch Immunol Ther Exp (Warsz). 2005 Jan-Feb;53(1):79-85.

Effects and side-effects of spironolactone therapy in women with acne.
Yemisci A, Gorgulu A, Piskin S.
J Eur Acad Dermatol Venereol. 2005 Mar;19(2):163-6.

The potential immunomodulatory effects of topical retinoids.
Jones DA.
Dermatol Online J. 2005 Mar 1;11(1):3. Review.

Isotretinoin therapy: any need for laboratory assessment?
Tallab T, Joharji H, Jazei M, Bahamdan K, Ibrahim K, Karkashan E.
West Afr J Med. 2004 Oct-Dec;23(4):273-5.

Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function.
Liu PT, Krutzik SR, Kim J, Modlin RL.
J Immunol. 2005 Mar 1;174(5):2467-70.

Postinflammatory hyperpigmentation in an Asian patient: a dramatic response to oral isotretinoin (13-cis-retinoic acid).
Winhoven SM, Ahmed I, Owen CM, Lear JT.
Br J Dermatol. 2005 Feb;152(2):368-9.

Lithium, minocycline, and pseudotumor cerebri.
Jonnalagadda J, Saito E, Kafantaris V.
J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):209.

Chloracne due to o-dichlorobenzene in a laboratory worker.
Violante FS, Milani S, Malenchini G, Barbieri A.
Contact Dermatitis. 2005 Feb;52(2):108.

RALGA (Diacneal), a retinaldehyde and glycolic acid association and postinflammatory hyperpigmentation in acne–a review.
Katsambas AD.
Dermatology. 2005;210 Suppl 1:39-45. Review.

Topical retinaldehyde with glycolic acid: study of tolerance and acceptability in association with anti-acne treatments in 1,709 patients.
Dréno B, Nocera T, Verrière F, Vienne MP, Ségard C, Vitse S, Carré C.
Dermatology. 2005;210 Suppl 1:22-9.

Efficacy and safety of 0.1% retinaldehyde/ 6% glycolic acid (diacneal) for mild to moderate acne vulgaris. A multicentre, double-blind, randomized, vehicle-controlled trial.
Poli F, Ribet V, Lauze C, Adhoute H, Morinet P.
Dermatology. 2005;210 Suppl 1:14-21.

Minocycline in neurological diseases.
Bandini F.
Lancet Neurol. 2005 Mar;4(3):138-9; discussion 139.

Isotretinoin, depression and suicide: a review of the evidence.
Magin P, Pond D, Smith W.
Br J Gen Pract. 2005 Feb;55(511):134-8. Review.

[The wider application of photodynamic therapy in dermatology].
Thissen MR, Kuijpers DI, Neumann HA.
Ned Tijdschr Geneeskd. 2005 Jan 29;149(5):232-7. Review. Dutch.

RU 58841-myristate–prodrug development for topical treatment of acne and androgenetic alopecia.
Münster U, Nakamura C, Haberland A, Jores K, Mehnert W, Rummel S, Schaller M, Korting HC, Zouboulis ChC, Blume-Peytavi U, Schäfer-Korting M.
Pharmazie. 2005 Jan;60(1):8-12.

A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
Gold MH, Rao J, Goldman MP, Bridges TM, Bradshaw VL, Boring MM, Guider AN.
J Drugs Dermatol. 2005 Jan-Feb;4(1):64-70.

The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
Shalita AR, Myers JA, Krochmal L, Yaroshinsky A; Clindamycin Foam Study Group.
J Drugs Dermatol. 2005 Jan-Feb;4(1):48-56.

In the clear from acne.
Setoodeh R.
Newsweek. 2005 Jan 10;145(2):57-8.

Diagnosis and treatment of polycystic ovarian syndrome.
Jones AE.
Nurs Times. 2005 Jan 18-24;101(3):40-3. Review.

Acne and milk, the diet myth, and beyond.
Danby FW.
J Am Acad Dermatol. 2005 Feb;52(2):360-2.

High school dietary dairy intake and teenage acne.
Adebamowo CA, Spiegelman D, Danby FW, Frazier AL, Willett WC, Holmes MD.
J Am Acad Dermatol. 2005 Feb;52(2):207-14.

Acne fulminans.
Mehrany K, Kist JM, Weenig RH, Witman PM.
Int J Dermatol. 2005 Feb;44(2):132-3.

[Immunohistochemical evidence of chronic inflammation in acne vulgaris].
Branisteanu D, Cianga C, Cianga P, Petrescu Z, Carasevici E.
Rev Med Chir Soc Med Nat Iasi. 2004 Apr-Jun;108(2):319-24. Romanian.

What is the pathogenesis of acne?
Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, Rosenfield R.
Exp Dermatol. 2005 Feb;14(2):143-52.

[Human beta defensins: a new perspective in acne treatment?].
Körber A, Lehnen M, Grabbe S, Dissemond J.
Dtsch Med Wochenschr. 2005 Feb 4;130(5):210-2. Review. German.

Medication-induced intracranial hypertension in dermatology.
Friedman DI.
Am J Clin Dermatol. 2005;6(1):29-37. Review.

Retinoid therapy for acne. A comparative review.
Chivot M.
Am J Clin Dermatol. 2005;6(1):13-9. Review.

Prevalence of different skin conditions in an outpatients’ setting in north-western Nigeria.
Onayemi O, Isezuo SA, Njoku CH.
Int J Dermatol. 2005 Jan;44(1):7-11.

Quality of life issues for South Africans with acne vulgaris.
Mosam A, Vawda NB, Gordhan AH, Nkwanyana N, Aboobaker J.
Clin Exp Dermatol. 2005 Jan;30(1):6-9.

Acne and its management beyond the age of 35 years.
Marks R.
Am J Clin Dermatol. 2004;5(6):459-62. Review.

Selecting an oral contraceptive agent for the treatment of acne in women.
van Vloten WA, Sigurdsson V.
Am J Clin Dermatol. 2004;5(6):435-41. Review.

Light-emitting diode-based therapy.
Abramovits W, Arrazola P, Gupta AK.
Skinmed. 2005 Jan-Feb;4(1):38-41. Review.

[How I treat… Belgian consensus document on the treatment of acne].
de la Brassinne M, De Weert J, Lambert J.
Rev Med Liege. 2004 Nov;59(11):626-9. Review. French.

A systematic review of the evidence for ‘myths and misconceptions’ in acne management: diet, face-washing and sunlight.
Magin P, Pond D, Smith W, Watson A.
Fam Pract. 2005 Feb;22(1):62-70. Review.

Two cases of acneiform eruption associated with lamotrigine.
Nielsen JN, Licht RW, Fogh K.
J Clin Psychiatry. 2004 Dec;65(12):1720-2.

Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
Shalita AR, Berson DS, Thiboutot DM, Leyden JJ, Parizadeh D, Sefton J, Walker PS, Gibson JR; Tazarotene Cream in Acne Clinical Study Investigator Group.
Clin Ther. 2004 Nov;26(11):1865-73.

Anakinra for flares of pyogenic arthritis in PAPA syndrome.
Dierselhuis MP, Frenkel J, Wulffraat NM, Boelens JJ.
Rheumatology (Oxford). 2005 Mar;44(3):406-8.

Understanding symptoms and management of skin disorders.
Freak J.
Nurs Times. 2004 Dec 7-13;100(49):34-7. Review.

Pityrosporum folliculitis: diagnosis and management in 6 female adolescents with acne vulgaris.
Ayers K, Sweeney SM, Wiss K.
Arch Pediatr Adolesc Med. 2005 Jan;159(1):64-7.

« Acne biofilms, » temperature, and microenvironments.
Burkhart CG.
J Am Acad Dermatol. 2005 Jan;52(1):182.

The use of salicylic acid in a new delivery system as a co-adjuvant topical treatment for acne vulgaris.
De Souza A, Christiansen C, Jamie S.
Aesthet Surg J. 2005 Jan-Feb;25(1):40-3.

The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris.
Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Carter LN.
J Drugs Dermatol. 2004 Nov-Dec;3(6 Suppl):S15-9.

Photodynamic therapy for the treatment of acne: a pilot study.
Taub AF.
J Drugs Dermatol. 2004 Nov-Dec;3(6 Suppl):S10-4.

Surgicel: a dressing for dermabrasion.
Sillitoe AT, Gaze N.
Plast Reconstr Surg. 2005 Jan;115(1):340-1.

Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial.
Ozolins M, Eady EA, Avery AJ, Cunliffe WJ, Po AL, O’Neill C, Simpson NB, Walters CE, Carnegie E, Lewis JB, Dada J, Haynes M, Williams K, Williams HC.
Lancet. 2004 Dec 18-31;364(9452):2188-95.

Mild cutaneous manifestation in two young women with extraordinary hyperandrogenemia.
Chen W, Chen GY, Tsai SJ, Wang PW, Sheu HM, Shen YS, Chen FF.
Dermatology. 2005;210(1):49-52.

The conundrum of skin pores in dermocosmetology.
Uhoda E, Piérard-Franchimont C, Petit L, Piérard GE.
Dermatology. 2005;210(1):3-7. Review.

Affective psychosis following Accutane (isotretinoin) treatment.
Barak Y, Wohl Y, Greenberg Y, Bar Dayan Y, Friedman T, Shoval G, Knobler HY.
Int Clin Psychopharmacol. 2005 Jan;20(1):39-41. Erratum in: Int Clin Psychopharmacol. 2005 May;20(3):182.

Center experience in liver transplantation (LTX): management of dermal side effects caused by sirolimus.
Schaffellner S, Jakoby E, Kniepeiss D, Stadlbauer V, Duller D, Iberer F, Tscheliessnigg KH.
Int Immunopharmacol. 2005 Jan;5(1):137-40.

Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
Ozolins M, Eady EA, Avery A, Cunliffe WJ, O’Neill C, Simpson NB, Williams HC.
Health Technol Assess. 2005 Jan;9(1):iii-212.

Abnormal production of tumor necrosis factor (TNF) — alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome [corrected].
Cortis E, De Benedetti F, Insalaco A, Cioschi S, Muratori F, D’Urbano LE, Ugazio AG.
J Pediatr. 2004 Dec;145(6):851-5. Erratum in: J Pediatr. 2005 Feb;146(2):193.

European recommendations on the use of oral antibiotics for acne.
Dréno B, Bettoli V, Ochsendorf F, Layton A, Mobacken H, Degreef H; European Expert Group on Oral Antibiotics in Acne.
Eur J Dermatol. 2004 Nov-Dec;14(6):391-9.

Use of macrolides and tetracyclines for chronic inflammatory diseases.
Voils SA, Evans ME, Lane MT, Schosser RH, Rapp RP.
Ann Pharmacother. 2005 Jan;39(1):86-94. Review.

Category : Acné - Modifie le 01.4.2011Category : acne vulgaris - Modifie le 01.4.2011